SavedAdd your journal

Journals / Journal of the Turkish-German Gynecological Association / 2007 / Cilt: 8 - Sayı: 3

Gebelikte güncel tarama

Contemporary screening in pregnancy

Mehmet Tunç CANDA
Namık DEMİR
Pages
332–338
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper we aimed to review the new approaches and current screening methods in pregnancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Screening tests and genetic sonogram have great importance in pregnancy management and follow-up.
📊
Key Findings & Data:First-trimester screen, second trimester screen and genetic sonogram have widespread use worldwide.
💡
Conclusion & Impact:In this paper we aimed to review the new approaches and current screening methods in pregnancy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Screening tests and genetic sonogram have great importance in pregnancy management and follow-up. First-trimester screen, second trimester screen and genetic sonogram have widespread use worldwide. Although some obstetricians still insist to use second trimester screening as a first line choice, first-trimester screening with ultrasound (including nuchal thickness, nasal bone, tricuspid regurgitation, ductus venosus blood flow) and biochemical tests are getting more pronounced rather than the second trimester screening test in the upcoming literature. In this paper we aimed to review the new approaches and current screening methods in pregnancy.

Özet

Gebelik yönetimi ve takibinde tarama testleri ve genetic sonografinin çok büyük önemi vardır. Birinci trimester taraması, ikinci trimester taraması ve genetic sonografi tüm dünya üzerinde yaygın olarak kullanılmaktadır. Ultrason (ense kalınlığı, nasal kemik, tricuspid regurjitasyonu, ductus venosus akımını içeren) ve biokimyasal testlerden oluşan birinci trimester taraması yeni literatürde ikinci trimester taramasından daha fazla vurgulanmaktadır, bununla birlikte, bazı obstetrisyenler halen ikinci trimester taramasını ilk tercih olarak kullanmakta ısrar etmektedirler. Biz bu yazıda yeni yaklaşımları ve güncel tarama yöntemlerini gözden geçirmeyi amaçladık.

🔖

Cite This Article

CANDA, M. T., DEMİR, N. (2022). Gebelikte güncel tarama. Journal of the Turkish-German Gynecological Association, Cilt: 8 - Sayı: 3, 332–338. https://ajindex.com/articles/567923

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rosen T and D’Alton ME. Down syndrome screening in the first and second trimesters: What do the data show? Semin Perinatol 2005;29:367-75
  2. Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down’s syndrome with the quadruple test. Lancet 2003;361:835-6
  3. Wald NJ, Rodeck C, Hackshaw AK et al. SURUSS Research Group. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening study (SURUSS). Health Technol Asses 2003;7:1-77
  4. Benacerraf BR, Frigoletto FD, Laboda LA. Sonographic diagnosis of Down syndrome in the second trimester. Am J Obstet Gynecol 1985;153:49-52
  5. Nicolaides KH, Azar G, Byrne D et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in the first trimester of pregnancy. BMJ 1992;304:867-9
  6. Bindra R, Heath V, Liao A et al. One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: A prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol 2002;20:219-25
  7. Ermis H. Nukal translusensi: 11-14. gebelik haftaları arasında trisomy taraması. T Klin Gynecol Obstet 2002;12:337-47
  8. Snijders RJ, Noble P, Sebire N et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343-6
  9. Braithwaite JM, Economides DL. The measurement of nuchal translucency with transabdominal and transvaginal sonography: success rates, repeatability and levels of agreement. Br J Radiol 1995;68:720-3
  10. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191:45-67
  11. Molina FS, Avgidou K, Kagan KO et al. Cystic higromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation. Obstet Gynecol 2006;107:678-83
  12. Chen M, Lam YH, Tang MH et al. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2002;22:576-8
  13. Spencer K, Ong CY, Liao AW et al. The influence of parity and gravidity on first trimester markers of chromosomal abnormality. Prenat Diagn 2000;20:792-4
  14. Niemimaa M, Heinoen S, Seppala M et al. The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotropin and nuchal translucency. BJOG 2003;110:664-7
  15. Bartha JL, Wood J, Kyle PM et al. The effect of metabolic control on fetal nuchal